Child sex ratio (CSR) in India has declined from 927 in 2001 to 918 in 2011 (girls per 1,000 boys), according to a new report entitled Missing Girls: Mapping the Adverse Child Sex Ratio in India (Census 2011). Of the total 640 districts in the country, 429 districts have experienced decline in CSR (see the link below).   Of these 429 districts, 26 districts exhibited drastic decline (of 50 points or more),...

-FirstPost.com Uncertainty over the supply of subsidised foodgrain to over 19 lakh families in Assam whose livelihoods are linked to work in the tea gardens is threatening to not only spark dissent among workers but has got the industry leaders worried. To understand the impact, consider the case of Deepak Daori and Monica Daori - both workers at Mokalbari Tea Estate in Dibrugarh district. "We are worried that the our monthly ration might...

-Economic and Political Weekly   The High-Level Committee set up by the Narendra Modi government to review the major laws relating to environment protection has, in its recommendations, worked towards two sets of objectives: one, to separate business from the messiness of governance, and, two, to redraw the line of demarcation between the judiciary and the executive. Manju Menon (manjumenon@namati.org) and Kanchi Kohli (kanchikohli@namati.org) are with the Centre for Policy Research - Namati...

-The Hindu It is not the responsibility of the government alone to act in order to curb corruption; corporate firms need to be proactive as well in checking fraudulent financial practices The winter session of Parliament witnessed a noisy debate on the black money controversy. Governments of all hues have disappointed the Indian janata on the issue of black money and the failure is often associated with a perceived nexus between politicians...

-The Times of India NEW DELHI: The drug price regulator has mandated companies to seek its approval for every new medicine, including combinations of existing ones, to ensure that consumers are not overcharged. According to the National Pharmaceutical Pricing Authority (NPPA) all innovative launches like new combinations of price-controlled medicines as well as those with changed strengths and dosages will be treated as 'new medicines'. The move is aimed at spanning the...